Table of Contents

1 Study Coverage

• 1.1 Drugs for Sinusitis Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Drugs for Sinusitis Market Size Growth Rate by Product
  • 1.4.2 Antibiotics
  • 1.4.3 Corticosteroids
  • 1.4.4 Decongestants
• 1.5 Market by End User
  • 1.5.1 Global Drugs for Sinusitis Market Size Growth Rate by End User
  • 1.5.2 Acute Sinusitis
  • 1.5.3 Chronic Sinusitis
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Drugs for Sinusitis Market Size
  • 2.1.1 Global Drugs for Sinusitis Revenue 2014-2025
  • 2.1.2 Global Drugs for Sinusitis Sales 2014-2025
• 2.2 Drugs for Sinusitis Growth Rate by Regions
  • 2.2.1 Global Drugs for Sinusitis Sales by Regions
  • 2.2.2 Global Drugs for Sinusitis Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Drugs for Sinusitis Sales by Manufacturers
  • 3.1.1 Drugs for Sinusitis Sales by Manufacturers
  • 3.1.2 Drugs for Sinusitis Sales Market Share by Manufacturers
  • 3.1.3 Global Drugs for Sinusitis Market Concentration Ratio (CR5 and HHI)
• 3.2 Drugs for Sinusitis Revenue by Manufacturers
  • 3.2.1 Drugs for Sinusitis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Drugs for Sinusitis Revenue Share by Manufacturers (2014-2019)
• 3.3 Drugs for Sinusitis Price by Manufacturers
• 3.4 Drugs for Sinusitis Manufacturing Base Distribution, Product Types
  • 3.4.1 Drugs for Sinusitis Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Drugs for Sinusitis Product Type
  • 3.4.3 Date of International Manufacturers Enter into Drugs for Sinusitis Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Drugs for Sinusitis Sales by Product
• 4.2 Global Drugs for Sinusitis Revenue by Product
• 4.3 Drugs for Sinusitis Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Drugs for Sinusitis Breakdown Data by End User

6 North America

• 6.1 North America Drugs for Sinusitis by Countries
  • 6.1.1 North America Drugs for Sinusitis Sales by Countries
  • 6.1.2 North America Drugs for Sinusitis Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Drugs for Sinusitis by Product
• 6.3 North America Drugs for Sinusitis by End User

7 Europe

• 7.1 Europe Drugs for Sinusitis by Countries
  • 7.1.1 Europe Drugs for Sinusitis Sales by Countries
  • 7.1.2 Europe Drugs for Sinusitis Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Drugs for Sinusitis by Product
• 7.3 Europe Drugs for Sinusitis by End User

8 Asia Pacific

• 8.1 Asia Pacific Drugs for Sinusitis by Countries
  • 8.1.1 Asia Pacific Drugs for Sinusitis Sales by Countries
  • 8.1.2 Asia Pacific Drugs for Sinusitis Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Drugs for Sinusitis by Product
• 8.3 Asia Pacific Drugs for Sinusitis by End User

9 Central & South America

• 9.1 Central & South America Drugs for Sinusitis by Countries
  • 9.1.1 Central & South America Drugs for Sinusitis Sales by Countries
  • 9.1.2 Central & South America Drugs for Sinusitis Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Drugs for Sinusitis by Product
• 9.3 Central & South America Drugs for Sinusitis by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Drugs for Sinusitis by Countries
  • 10.1.1 Middle East and Africa Drugs for Sinusitis Sales by Countries
  • 10.1.2 Middle East and Africa Drugs for Sinusitis Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Drugs for Sinusitis by Product
• 10.3 Middle East and Africa Drugs for Sinusitis by End User

11 Company Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sanofi Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sanofi Drugs for Sinusitis Products Offered
  • 11.1.5 Sanofi Recent Development
• 11.2 Bayer AG
  • 11.2.1 Bayer AG Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bayer AG Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bayer AG Drugs for Sinusitis Products Offered
  • 11.2.5 Bayer AG Recent Development
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Pfizer Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Pfizer Drugs for Sinusitis Products Offered
  • 11.3.5 Pfizer Recent Development
• 11.4 AstraZeneca Plc
  • 11.4.1 AstraZeneca Plc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 AstraZeneca Plc Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 AstraZeneca Plc Drugs for Sinusitis Products Offered
  • 11.4.5 AstraZeneca Plc Recent Development
• 11.5 Novartis AG.
  • 11.5.1 Novartis AG. Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Novartis AG. Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Novartis AG. Drugs for Sinusitis Products Offered
  • 11.5.5 Novartis AG. Recent Development
• 11.6 Johnson & Johnson
  • 11.6.1 Johnson & Johnson Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Johnson & Johnson Drugs for Sinusitis Products Offered
  • 11.6.5 Johnson & Johnson Recent Development
• 11.7 Merck
  • 11.7.1 Merck Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Merck Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Merck Drugs for Sinusitis Products Offered
  • 11.7.5 Merck Recent Development
• 11.8 Amgen
  • 11.8.1 Amgen Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Amgen Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Amgen Drugs for Sinusitis Products Offered
  • 11.8.5 Amgen Recent Development
• 11.9 Bionorica SE
  • 11.9.1 Bionorica SE Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Bionorica SE Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Bionorica SE Drugs for Sinusitis Products Offered
  • 11.9.5 Bionorica SE Recent Development
• 11.10 Dr. Reddy's Laboratories
  • 11.10.1 Dr. Reddy's Laboratories Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Dr. Reddy's Laboratories Drugs for Sinusitis Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Dr. Reddy's Laboratories Drugs for Sinusitis Products Offered
  • 11.10.5 Dr. Reddy's Laboratories Recent Development
• 11.11 Huasun

12 Future Forecast

• 12.1 Drugs for Sinusitis Market Forecast by Regions
  • 12.1.1 Global Drugs for Sinusitis Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Drugs for Sinusitis Revenue Forecast by Regions 2019-2025
• 12.2 Drugs for Sinusitis Market Forecast by Product
  • 12.2.1 Global Drugs for Sinusitis Sales Forecast by Product 2019-2025
  • 12.2.2 Global Drugs for Sinusitis Revenue Forecast by Product 2019-2025
• 12.3 Drugs for Sinusitis Market Forecast by End User
• 12.4 North America Drugs for Sinusitis Forecast
• 12.5 Europe Drugs for Sinusitis Forecast
• 12.6 Asia Pacific Drugs for Sinusitis Forecast
• 12.7 Central & South America Drugs for Sinusitis Forecast
• 12.8 Middle East and Africa Drugs for Sinusitis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Drugs for Sinusitis Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.

Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field. The most proportion of Drugs for Sinusitis is Orthopedics, Musculoskeletal &Spine, and the revenue in 2015 is 2387.4 M USD.

North America region is the largest supplier of Drugs for Sinusitis, with a revenue market share nearly 35% in 2015. Europe is the second largest supplier of Drugs for Sinusitis, enjoying revenue market share nearly 27% in 2015.

North America is the largest consumption place, with a consumption market share nearly 35% in 2015. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.

Sanofi, Bayer AG, Pfizer etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

The global Drugs for Sinusitis market is valued at 1950 million US$ in 2018 and will reach 2600 million US$ by the end of 2025, growing at a CAGR of 3.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drugs for Sinusitis market based on company, product type, end user and key regions.

This report studies the global market size of Drugs for Sinusitis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Sinusitis in these regions.
This research report categorizes the global Drugs for Sinusitis market by top players/brands, region, type and end user. This report also studies the global Drugs for Sinusitis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy's Laboratories
Huasun

Market size by Product
Antibiotics
Corticosteroids
Decongestants
Market size by End User
Acute Sinusitis
Chronic Sinusitis

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drugs for Sinusitis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drugs for Sinusitis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drugs for Sinusitis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drugs for Sinusitis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drugs for Sinusitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drugs for Sinusitis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.